NSE:JAGSNPHARM - Jagsonpal Pharmaceuticals Limited Stock Price & Analysis

About Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

(NSE:JAGSNPHARM) Jagsonpal Pharmaceuticals Limited develops and manufactures pharmaceuticals products and active pharmaceutical ingredients worldwide. It offers active pharmaceutical ingredients, which include allylestrenol, dextropropoxyphene HCL, dextropropoxyphene napsylate, disulfiram, thiopental sodium, thiopental acid, tolnaftate, and sildenafil citrate, as well as metformin HCL, BP, USP, and EP. The company also provides formulations for various therapeutic categories, such as anabolic steroids, analgesics, anesthetics, anti-allergic, anti-asthamatics, anti-cholinergic agents, anti-convulsants, anti-diabetics, anti-diarrhoeals, anti-emetics, anti-epileptics, anti-fungal agents, anti-gout agents, anti-inflammatory agents, anti-malarials, anti-nauseants, anti-protozoals, anti-pyretic, anti-rheumatic drugs, anti-spasmodic agents, and anti-septic agents. In addition, it offers anti-tubercular drugs, anti-ulcerants, anxiolytics, cardiovascular drugs, corticosteroids, cough syrups, diuretics, drugs for alcohol dependence, GI anti-infectives, haematinics, imaging agents, laxatives, male/female hormones, multivitamins, nutraceuticals, ophthalmic lubricants, oral rehydrating salts, sedative-hypnotics, softgels, systemic anti-infectives, throat pain sprays, tonics, and uterine stimulants. The company sells its products primarily under the Lycored, Maintane, Metadec, Metabol, Doxypal DR, Parvon, and Indocap SR brand names. Jagsonpal Pharmaceuticals Limited was founded in 1964 and is based in New Delhi, India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.

JAGSNPHARM Stock Price

Statistics Highlights (NSE:JAGSNPHARM)

Shares Outstanding	26.20M	Beta	1.24
Public Float	6.95M	P/E Ratio	25.80
% Short of Float	-	Dividend (Yield)	-
Held by Insiders	75.13%	Ex-Dividend Date	Oct 29, 2021
Held by Institutions	-	IPO Date	-

Explore More on "Statistics" Section

JAGSNPHARM Financial Summary

|

	Mar 21	Mar 20	Mar 19
Revenue	INR1.88B	INR1.59B	INR1.67B
EBITDA	INR233.86M	INR109.28M	INR104.63M
Net Income	INR170.58M	INR78.71M	INR72.16M
Total Assets	INR1.64B	INR1.47B	INR1.36B
Total Cash	INR589.43M	INR380.74M	INR385.35M
Total Debt	INR68.06M	INR46.65M	INR37.85M

	Dec 21	Sep 21	Jun 21
Revenue	INR544.74M	INR594.89M	INR599.99M
EBITDA	INR75.65M	INR105.66M	INR100.96M
Net Income	INR54.06M	INR73.07M	INR68.48M
Total Assets	INR	INR1.93B	INR
Total Cash	INR	INR466.62M	INR
Total Debt	INR	INR69.57M	INR

JAGSNPHARM Stock Price History

Jagsonpal Pharmaceuticals Limited Annual Stock Price History

Year	Open	Close	Change
2021	INR180.25	INR176.40	-2.14%
2021	INR72.00	INR180.25	150.35%
2020	INR25.00	INR72.00	188.00%

Jagsonpal Pharmaceuticals Limited Daily Stock Price History

Date	Open	High	Low	Close	Change	Volume
Jun 17, 2022	INR277.00	INR285.00	INR270.25	INR274.10	-6.90%	33.63K
Jun 14, 2022	INR294.95	INR302.45	INR290.05	INR294.40	-0.36%	35.01K
Jun 9, 2022	INR292.00	INR297.05	INR292.00	INR295.45	-2.23%	15.39K

View More on "Price History" Section

(NSE:JAGSNPHARM) Stock Price FAQs

What is today's stock price of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)?

The current stock price of Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) is INR176.40.
Today JAGSNPHARM stock price opened at INR178.00 after previous close of INR179.25.
During the day, Jagsonpal Pharmaceuticals Limited stock quote has varied from a low of INR175.25 to a high of INR180.60.

What is Jagsonpal Pharmaceuticals Limited's 52-week change?

JAGSNPHARM 52-week high stock quote is INR267.00, which is 51.40% above the current share price.
The Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) 52-week low stock price is INR73.01, which is 58.60% below the current share price.
Jagsonpal Pharmaceuticals Limited share price volatility (52-week beta) is 1.24.

Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) FAQ

How Much is Jagsonpal pharmaceuticals limited Worth?

Jagsonpal pharmaceuticals limited's worth today based on market capitalisation is INR6.36B

How much dividend does Jagsonpal pharmaceuticals limited Pay?

The current annualized dividend payout for JAGSNPHARM stock is INR5.00, the dividend yield is 2.12% and the payout ratio is 53.13%.
View More Details on Jagsonpal pharmaceuticals limited's "Dividend" Section

What is Jagsonpal pharmaceuticals limited’s Price to Earning (PE) ratio?

Jagsonpal pharmaceuticals limited has a Price to Earning (P/E) ratio of 25.80. JAGSNPHARM stock also has a Price to Sales (P/S) ratio of 2.93.

What is the Jagsonpal pharmaceuticals limited's ticker?

Jagsonpal pharmaceuticals limited trades on the NSE stock market in India under the ticker symbol "JAGSNPHARM". Jagsonpal pharmaceuticals limited’s stock symbol can also be displayed as "NSE:JAGSNPHARM".

Who are the owners of Jagsonpal pharmaceuticals limited?

Jagsonpal pharmaceuticals limited (NSE:JAGSNPHARM) is owned by 0.00% institutional shareholders and by 75.13% insiders. The rest is owned by the public.
Explore More Details on Jagsonpal pharmaceuticals limited's “Ownership” Section

Who are the key executives of Jagsonpal pharmaceuticals limited (JAGSNPHARM)?

Jagsonpal pharmaceuticals limited's key executive team includes the following managers:

Mr. Rajpal P. Singh Kochhar, Chairman & MD (1955)
Ms. Nandita Singh, Company Sec. & Compliance Officer (NA)
Mr. S. V. Subha Rao, Chief Financial Officer (NA)
Mr. Prithipal Singh Kochhar, VP of International Bus. and International Marketing (1979)
Bharat Chugh, Assistant Gen. Mang. of HR (NA)

What is Jagsonpal pharmaceuticals limited’s Sector & Industry Classification?

Jagsonpal pharmaceuticals limited (NSE:JAGSNPHARM) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

How many employees work for Jagsonpal pharmaceuticals limited?

Currently the number of employees working for Jagsonpal pharmaceuticals limited is 0.

Where are Jagsonpal pharmaceuticals limited's Headquarters?

Jagsonpal pharmaceuticals limited (NSE:JAGSNPHARM) is headquartered in India.

What are Jagsonpal pharmaceuticals limited's Address and Phone Number?

Jagsonpal pharmaceuticals limited’s mailing address is T-210 J, Shahpur Jat, New Delhi, India, 110049.
The company’s phone number is 91 11 4618 1100.

What is the official website for Jagsonpal pharmaceuticals limited?

Jagsonpal pharmaceuticals limited’s official website is http://www.jagsonpal.com

Jagsonpal Pharmaceuticals Limited Stock (NSE:JAGSNPHARM)